Coave Therapeutics Strengthens Board of Directors

Paris, France, October 20th, 2022…

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Coave Therapeutics to Collaborate with…

Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board

Coave Therapeutics appoints Olivier Danos…